← All patents

US20120269825A1

Methods of modulating the ox40 receptor to treat cancer

University of Texas System

Abstract

Numerous disease states, such as human allergic, autoimmune, and autoimmune diseases, and cancer, may be treated by targeting OX40/OX40L. OX40L inhibits the generation of Tr1 cells from naïve and memory CD4+ T cells. This unique function of OX40L is not shared by two other costimulatory TNF-family …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Yong-Jun Liu
Priority date
January 13, 2006
Filing date
April 26, 2012
Publication date
October 25, 2012
Language
en
Metadata fetched
August 29, 2026 00:20